Hepatic Infiltrates in Operational Tolerant Patients after Liver Transplantation Show Enrichment of Regulatory T Cells before Proinflammatory Genes Are Downregulated

American Journal of Transplantation

Volumn 16, Issue 4, 2016, Pages 1285-1293

  Taubert, R ^a   Danger, R ^b   Londono M C ^c   Christakoudi, S ^d   Martinez Picola, M ^c   Rimola, A ^b   Manns, M P ^a   Sanchez Fueyo A ^b,c   Jaeckel, E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; AUTACOID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG WITHDRAWAL; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPHENOTYPING; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATOR GENE; REGULATORY T LYMPHOCYTE; SPONTANEOUS OPERATIONAL TOLERANCE; TRANSPLANTATION TOLERANCE; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LIVER DISEASES; METABOLISM; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK FACTOR;

ADULT; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 84959086240     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13617     Document Type: Article

References (30)

1. Gelson W, Hoare M, Dawwas MF, Vowler S, Gibbs P, Alexander G,. The pattern of late mortality in liver transplant recipients in the United Kingdom. Transplantation 2011; 91 (11): 1240-1244.
2. Di Cocco P, Bonanni L, D'Angelo M, et al., Clinical operational tolerance after solid organ transplantation. Transplant Proc 2009; 41 (4): 1278-1282.
3. Knechtle SJ, Kwun J,. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 2009; 29 (1): 91-101.
4. Sanchez-Fueyo A,. Hot-topic debate on tolerance: Immunosuppression withdrawal. Liver Transpl 2011; 17 (Suppl 3): S69-S73.
5. Crispe IN,. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003; 3 (1): 51-62.
6. Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P,. The liver: A special case in transplantation tolerance. Semin Liver Dis 2007; 27 (2): 194-213.
7. Li W, Kuhr CS, Zheng XX, et al., New insights into mechanisms of spontaneous liver transplant tolerance: The role of Foxp3-expressing CD25 + CD4 + regulatory T cells. Am J Transplant 2008; 8 (8): 1639-1651.
8. Bishop GA, Bertolino PD, Bowen DG, McCaughan GW,. Tolerance in liver transplantation. Best Pract Res Clin Gastroenterol. 2012; 26 (1): 73-84.
9. Martinez-Llordella M, Puig-Pey I, Orlando G, et al., Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7 (2): 309-319.
10. Li Y, Koshiba T, Yoshizawa A, et al., Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4 (12): 2118-2125.
11. Ohe H, Waki K, Yoshitomi M, et al., Factors affecting operational tolerance after pediatric living-donor liver transplantation: Impact of early post-transplant events and HLA match. Transpl Int 2012; 25 (1): 97-106.
12. Tokita D, Mazariegos GV, Zahorchak AF, et al., High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation. 2008; 85 (3): 369-377.
13. Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW,. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 2005; 5 (2): 314-322.
14. Castellaneta A, Mazariegos GV, Nayyar N, Zeevi A, Thomson AW,. HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Transplantation 2011; 91 (10): 1132-1140.
15. Yoshitomi M, Koshiba T, Haga H, et al., Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009; 87 (4): 606-614.
16. Li Y, Zhao X, Cheng D, et al., The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008; 86 (12): 1837-1843.
17. Bohne F, Martinez-Llordella M, Lozano JJ, et al., Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122 (1): 368-382.
18. Benitez C, Londono MC, Miquel R, et al., Prospective multi-center clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology. 2013; 58: 1824-1835.
19. Feng S, Ekong UD, Lobritto SJ, et al., Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012; 307 (3): 283-293.
20. Taubert R, Pischke S, Schlue J, et al., Enrichment of regulatory T cells in acutely rejected human liver allografts. Am J Transplant 2012; 12 (12): 3425-3436.
21. He Q, Fan H, Li JQ, Qi HZ,. Decreased circulating CD4 + CD25highFoxp3 + T cells during acute rejection in liver transplant patients. Transplant Proc 2011; 43 (5): 1696-1700.
22. Issa F, Hester J, Milward K, Wood KJ,. Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model. PLoS One 2012; 7 (12): e53331.
23. Taubert R, Hardtke-Wolenski M, Noyan F, et al., Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. J Hepatol 2014; 61 (5): 1106-1114.
24. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9 (10): 2312-2323.
25. Bohne F, Londono MC, Benitez C, et al., HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans. Sci Transl Med. 2014; 6 (242): 242ra81.
26. Gagliani N, Gregori S, Jofra T, et al., Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One 2011; 6 (12): e28434.
27. Wekerle T,. T-regulatory cells-what relationship with immunosuppressive agents? Transplant Proc 2008; 40 (10 Suppl): S13-S16.
28. Sagoo P, Lombardi G, Lechler RI, Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol. 2012; 3: 184.
29. Miyara M, Yoshioka Y, Kitoh A, et al., Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 2009; 30 (6): 899-911.
30. Levitsky J, Mathew JM, Abecassis M, et al., Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. Hepatology. 2012; 57: 239-248.